Skip to main content

Tiotropium News

FDA Expands Approval of Spiriva Respimat (tiotropium bromide) Inhalation Spray for Maintenance Treatment of Asthma in Children

RIDGEFIELD, Conn., February 16, 2017 - Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Spiriva Respimat for the long-term,...

FDA Approves Spiriva Respimat (tiotropium) for Maintenance Treatment of Asthma in Adults and Adolescents

RIDGEFIELD, Conn., September 16, 2015 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Spiriva Respimat for the long-term, o...

FDA Approves Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray for COPD

RIDGEFIELD, Conn., May 26, 2015 – Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) approved once-daily Stiolto Respimat (tiotropium bromide and olodaterol) I...

FDA Approves Spiriva Respimat (tiotropium) for the Maintenance Treatment of COPD

Ridgefield, Conn., September 25, 2014 – Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Spiriva Respimat (tiotropium bromide) i...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Asthma - Maintenance, Chronic Obstructive Pulmonary Disease

Related drug support groups

Spiriva

Tiotropium patient information at Drugs.com